Could FDA End Deadly Antibiotic Drug Trials?

A few weeks ago, I told you about Ketek (telithromycin), a faulty antibiotic used to treat asthma, approved by the FDA despite reports of liver damage, blurred vision and a loss of consciousness in adults.

Apparently, someone at the FDA has been paying closer attention to those dangers, according to a memo cited in an excellent New York Times report. A government official at the agency called for an end to clinical trials, testing Ketek as a treatment for tonsillitis and ear infections involving some 4,000 children worldwide and ranging in age from 6 months to 13 years.

In fact, FDA safety officials believe Ketek is unusually toxic, evidenced by 12 American adults who have suffered liver failure, 23 with liver injuries and four patient deaths. What's more, the FDA estimates Ketek harms close to four times the number of patients taking any other antibiotic.

Amazing how drug companies and the FDA still push drug-based solutions when the evidence is clear they do no good. Meantime, if you're been looking for safe, effective and natural techniques for treating earaches without drugs, you'll want to review Colleen Huber's awesome article.

New York Times June 8, 2006 Registration Required

Seattle Post-Intelligencer June 8, 2006

Post your comment
Click Here and be the first to comment on this article